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Aim: The study objective was the investigation of psychosocial variables affecting
the disease trajectory in patient diagnosed with cystic ﬁbrosis (CF). In addition, we
analysed the impact of socioeconomic status on patients’ health status.
Method: Between 2000 and 2009 all patients treated at the CF Centre at Innsbruck
Medical University and aged below 18 (n = 103) were included in the study and
assessed longitudinally. As measures of physical health status we recorded lung
function values and body mass index (BMI). Psychosocial status was assessed using
the Cystic Fibroses Problemchecklists (CFPC) and Hospital Anxiety and Depression
Scale (HADS). Lung function and BMI were recorded quarterly. Psychosocial and
sociodemographic variables were collected annually at routine examinations.
Results: Our results suggest a strong association between mother’s marital status
and lung function (mean FEV1: single parent 82.1% vs. parent with spouse 96.2%).
In addition, we found an impact of mother’s educational status on lung function
(mean FEV1: compulsory school 79.6% vs. university degree 98.6%). We did not
ﬁnd any signiﬁcant association with BMI and psychosocial variables.
Conlusion: A strong impact of education and marital status on the child’s health
status was found, although in Austria treatment costs are fully covered by general
health insurance and all patients receive the same treatment. We conclude that it is
essential to turn attention to the parent’s marital and educational status. To be able
to prevent a negative impact, further research is necessary to investigate how these
factors affect lung function.
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Background: The patient’s experiences are important for developing the best
possible care for chronically ill patients. As general patient surveys do not cover
speciﬁc aspects of multi-professional care, we aimed to develop a disease speciﬁc
questionnaire for CF patients and parents.
Methods: Expert interviews were carried out in 2 centres, and focus group
discussions were conducted in 3 centres with 7 adult CF patients and 13 parents
of children with CF. Audio tapes were used to extract relevant themes. Pilot
questionnaires for parents and adult patients (18 y) were mailed to participants
from 4 CF centres, and responses were analysed to establish the modiﬁed ﬁnal
versions.
Results: Based on focus group discussions new items were identiﬁed which were
not part of general Picker questionnaires on patient satisfaction, e.g. hygiene, multi-
professional staff, accessibility, and support by the centre. The pilot questionnaires
were mailed to 389 participants, with response rates of 83% and 69% in parents
and adults, respectively. 22% of subjects provided suggestions to improve the
questionnaires. Most respondents were satisﬁed with their care, although room for
improvement was identiﬁed, e.g. insufﬁcient information on side effects of drugs,
or delayed information on test results.
Conclusion: We have developed CF speciﬁc questionnaires to investigate patients’
and parents’ experience and satisfaction with care. These can be used for quality
improvement measures and benchmarking.
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Background: We have developed and undertaken preliminary validation of a
questionnaire tool to measure the challenge of living with cystic ﬁbrosis (the CLCF
questionnaire). This parent reported outcome has been developed in partnership
with families and has a number of components including measures of time and
effort.
Aim: To use the CLCF questionnaire to examine the impact of pulmonary exacer-
bation on the challenge of caring for a child with CF.
Method: Parents of children with CF aged 13, at least one year post diagnosis,
were enrolled. They completed the CLCF during a period of stability and pulmonary
exacerbation (PEx), deﬁned by two or more classical symptoms of PEx. The number
of minutes per day undertaking treatment tasks and the average effort expended in
treatment tasks were compared at the two time points.
Results: Thirty-two families enrolled into the study, and 13 completed the CLCF
at both time points. Nine of the thirteen parents reported an increased treatment
time during their child’s pulmonary exacerbation, one reported no change, and three
reported a fall in treatment time (p> 0.05). The median (IQR) increase in treatment
time was 53 minutes (−16.5, 101.5). There was no signiﬁcant change in effort.
However, there was a correlation between the within person difference in minutes
per day and the within person difference in average effort (p = 0.024).
Conclusions: The results indicate that parents experience an increased time demand
during PEx, and that the concepts of time and effort are related. This study provides
further evidence to support the face validity of the CLCF as a tool for measuring
the burden for families of caring for a child with CF.
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Background: There is no standardised deﬁnition of a pulmonary exacerbation in
cystic ﬁbrosis (CF). In attempting to achieve standardised criteria it is important to
identify patient-reported indicators. Interviews with adults suggest that they report
symptoms of an exacerbation in different ways according to disease severity. This
work reports on interviews with children employing similar methodology.
Methods: Interviews were undertaken with 26 children with CF (aged 8−15 years)
who had experience of pulmonary exacerbations. They were asked to report symp-
toms experienced during a pulmonary exacerbation in two ways: the ﬁrst symptoms
they become aware of, and how they subsequently recognised when they were
improving. Purposive sampling ensured representation of key variables including
age, gender, in/out-patient, large/small CF unit, FEV1% predicted, BMI, nutritional
status, microbiology, and recorded exacerbations in the past year. Interviews were
taped, transcribed verbatim and the data analysed thematically.
Results: A range of systemic and respiratory symptoms were reported. For
many children the onset of an exacerbation was primarily characterised by ‘cold’
symptoms, tiredness, and changes in cough and sleep. When describing their
improvement from an exacerbation the children tended to focus initially on activities
they were now able to perform (e.g. playing, school work).
Conclusion: These preliminary data suggest that child-reported indicators of a
pulmonary exacerbation tended to map onto those reported by adults with mild
disease. Validity checks on these results are required prior to their contribution to
the development of standardised criteria.
